ADVANCES IN ORAL INSULIN DELIVERY

Similar documents
Experiment 2 Introduction

Influence of Molecular Weight and Degree of Deacetylation of Low Molecular Weight Chitosan on the Bioactivity of Oral Insulin Preparations

GLUCOSE OXIDASE

Chapter 2 Rationale and Objective

RUBISCO > 2 moles of 3-phosphoglycerate Mg +2

AMYLOGLUCOSIDASE from ASPERGILLUS NIGER, var.

Glutathione Peroxidase Assay Kit

PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature

Glutathione Reductase Assay Kit

Revised European Guideline on PK and Clinical Evaluation of Modified Release Dosage Forms

2-Deoxyglucose (2DG) Uptake Measurement kit

Experiment 1. Isolation of Glycogen from rat Liver

Enzymatic Assay of GALACTOSYLTRANSFERASE (EC )

Enzymatic Assay of URIDINE 5'-DIPHOSPHOGALACTOSE 4-EPIMERASE (EC )

Western Immunoblotting Preparation of Samples:

Enzymatic Assay of NAD-PYROPHOSPHORYLASE (EC )

OxisResearch A Division of OXIS Health Products, Inc.

UV Tracer TM Maleimide NHS ester

Supplementary Figure 1 Detailed description of the MDP fabrication procedures

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

ARABINAN

Preparation of Penicillins by Acylation of 6-Aminopenicillanic acid with Acyl Chlorides Week One: Synthesis

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Most of the ethanol that is used as a biofuel in this country is produced from corn.

SUMMARY, CONCLUSION & RECOMMENDATIONS

Bioequivalence Requirements: USA and EU

MATERIAL AND METHODS

jetsi 10 mm in vivo sirna/mirna delivery to the brain PROTOCOL

Type I Type II Insulin Resistance

ASSAY OF using CELLAZYME C TABLETS T-CCZ 01/17

Cholesterol/Cholesteryl Ester Detection Kit

Enzymatic Assay of RIBONUCLEIC ACID POLYMERASE 1 (EC )

Measuring Lipid Composition LC-MS/MS

ab Dipeptidyl peptidase IV (DPP4) Inhibitor Screening Assay Kit

Glucose Assay Kit. Catalog Number KA assays Version: 07. Intended for research use only.

Item Catalog Number Manufacturer 1,4-Dithioerythritol (1 g) D9680 Sigma-Aldrich

Protocol for Gene Transfection & Western Blotting

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Supporting Information

ab Lipoxygenase Inhibitor Screening Assay Kit

AMPK Assay. Require: Sigma (1L, $18.30) A4206 Aluminum foil

Cuvette Assay for GSH/GSSG (Reduced/Oxidized Glutathione) For Research Use Only INTRODUCTION

Change to read: BRIEFING

STABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.

Glucose 6 Phosphate Assay Kit (Colorimetric)

ab HRP Substrate Instructions for Use

jetsi 10 mm sirna delivery reagent for the brain

ASSAY OF using AZO-FRUCTAN S-AZFR5 11/17

Data sheet. TBARS Assay kit. (Colorimetric/Fluorometric) Kit Contents. MDA-TBA Adduct. 2-Thiobarbituric Acid. Cat. No: CA995.

Enhancement of oral bioavailability of insulin in humans

Free Fatty Acid Assay Kit

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

2-Deoxyglucose Assay Kit (Colorimetric)

The Schedule and the Manual of Basic Techniques for Cell Culture

Experiment Optional #2: The Synthesis of Aspirin

Enzymatic Assay of PHOSPHODIESTERASE, 3':5'-CYCLIC NUCLEOTIDE Crude Complex

RayBio Maltose and Glucose Assay Kit

Media preparation. To Prepare A ml stock soln (B X) Dissolve (Concn in medium (mg/ml) X A X B) mg In total volume A ml.

5. Formulation and Development of Microemulsion and SMEDDS

Enzymatic Assay of PHOSPHORYLASE KINASE (EC )

-Glucan (mixed linkage), colorimetric method

MALTOSE, SUCROSE and D-GLUCOSE

MEK1 Assay Kit 1 Catalog # Lot # 16875

For the rapid, sensitive and accurate measurement of Triglyceride in various samples.

BIOL 347L Laboratory Three

12BL Experiment 2: Extraction & Saponification of Trimyristin from Nutmeg

HT Glutathione Assay Kit

SALIVA TEST Introduction

Nitrate/Nitrite Assay Kit Manual Catalog #

ASSAY OF USING BETA-GLUCAZYME TABLETS

Experiment 3. Potentiometric Titration Using a ph Electrode. information necessary for both purposes by monitoring the ph of the solution as the

Unigel TM Case Study: Extending Soft Gelatin Capsule Benefits to Novel Fixed Dose Combinations

Research Article DEVOLOPMENT OF RP-HPLC METHOD AND IT S VALIDATION FOR SIMULTANEOUS ESTIMATION OF SITAGLIPTIN AND METFORMIN

GPx Equation 1 Æ R - O - H + GSSG + H2 O

Glucose Uptake Colorimetric Assay Kit

AZO-XYLAN (BIRCHWOOD)

ASSAY OF SPHINGOMYELINASE ACTIVITY

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

EFFECT OF STARCH HYDROLYSATES IN THE PROCESS OF DISSOLUTION OF SOLIDS

Acetyl-CoA Assay Kit. Catalog Number KA assays Version: 04. Intended for research use only.

beta Hydroxybutyrate (beta HB) Assay Kit

RECONSTITUTION, DOSING AND ADMINISTRATION

PRESCRIBING INFORMATION. Dextrose Injection USP. (Concentrated Dextrose for Intravenous Administration) 50% (500 mg/ml) Fluid and Nutrient Replenisher

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

5 Application of the ESR online-method for the monitoring of nanocapsule digestion

CRYSTALOMICS FORMULATION TECHNOLOGY

Abstract. G. D. Patil 1, P. G. Yeole 1, Manisha Puranik 1 and S. J. Wadher 1 *

PECTIN IDENTIFICATION

Evaluation of combination drugs before the development of self-emulsifying drug delivery system

OxisResearch A Division of OXIS Health Products, Inc.

Acetyl-CoA Assay Kit. Catalog Number KA assays Version: 03. Intended for research use only.

SUCROSE/ D-GLUCOSE

Enzymatic Assay of GLUCONATE KINASE (EC ) ß-NADPH = ß-Nicotinamide Adenine Dinucleotide Phosphate,

THE UNIVERSITY OF NEWCASTLE- DISCIPLINE OF MEDICAL BIOCHEMISTRY

Enzymatic Assay of PHOSPHOLIPASE C (EC )

Enzymatic Assay of CHOLINE KINASE (EC )

PHARMACODYNAMIC EFFECTS OF CIMETIDINE AND METRONIDAZOLE ON THE BLOOD GLUCOSE LOWERING EFFECT OF GLYBURIDE IN RATS.

Transcription:

ADVANCES IN ORAL INSULIN DELIVERY Zakieh I. Al-Kurdi, Babur Z. Chowdhry, Nidal A. Qinna, Mahmoud M.H. Al Omari and Adnan A. Badwan 2 ND MENA REGULATORY CONFERENCE ON BIOEQUIVALENCE, BIOWAIVERS, BIOANALYSIS, DISSOLUTION AND BIOSIMILARS Jordan September 15-17, 2015

Background Insulin Oral Delivery Challenge Experimental Work Content Glucosamine Effect Glutathione Effect Results and Conclusion 2

Insulin is the most used medicine for diabetes mellitus 3

Insulin can be delivered by injection or by other delivery systems, among these is the oral route 4

In order to deliver insulin orally it must be modified by: Chemical Methods : New Moieties Physical Methods : Formulations 5

Various attempts to deliver insulin orally are at different stages of development. Their main focus is to deliver oral insulin using solid and liquid dosage forms 6

Among these is an internationally patented technology where a polyelectrolyte insulin-chitosan complex is formed and solubilized in a reverse micelle 7

8

This patented system was conceptually proved and tested on 50 human healthy volunteers 9

The challenge is to improve the bioactivity of the tested formulations 10

Strategy followed is to minimize metabolism of insulin in liver 11

Glutathione dehydrogenase is responsible for ⅓ of insulin metabolism Glucosamine HCL was found to reduce or inhibit metabolism of many small molecules 12

Delivered insulin concentration Glucosamine effect on delivered insulin Glutathione oxidized and reduced effect on delivered insulin 13

Dissolve 100mg of insulin 1ml of 0.1M HCl Dilute in 3ml of 1M TRIS buffer ph 7.0 In a separate vial, dissolve 125mg of 13KDa Chitosan (99% DDA) in 5ml of dh 2 O Solubilized Insulin in Reverse Micelle Preparation Adjust the ph of chitosan solution to 5.5 using 0.2N NaOH Equal volumes of 25mg/ml insulin solution and 25mg/ml chitosan solution are mixed gently with frequent inversions Glutathione or Glucosamine complexes are added to aqueous phase Oily Base Weigh the following into a beaker: oleic acid (16g), labrasol (2g), and plurol (2g), and stir for 10 minutes Add 400μl of the PEC dropwise in 20g of the oily base (2%, v/v) with vortexing for 30 seconds. 14

Changes in % glucose levels (n=10) versus time profiles of STZ diabetic rats injected initially with multiple doses of insulin (0.5, 0.75 and 1 IU/kg) every two hours followed by oral glucose administration (50 mg/rat) post 6 hours of blood glucose measurements. % Glucose levels were significantly different post oral glucose administration (p < 0.05). 15

Cumulative release of insulin from the IC-RMs using LMWC (13 kda). 16

Effect of GlcN HCl SC administration on insulin bioactivity. Notes: GlcN HCl solution was SC injected with doses of 0, 50,100 and 200 mg/kg prior to SC insulin (1 IU/kg) administration. The reduction in blood glucose levels was confirmed to be significant as P values were < 0.01. Abbreviations: GlcN, glucosamine; SC, subcutaneous; IU, insulin unit. 17

Effect of simultaneous SC insulin-glcn HCl administration on insulin bioactivity. Notes: Insulin-GlcN HCl mixture solutions of mass ratio 1:0, 1:1, 1:4, 1:10 and 1:20 were SC injected (1 IU/kg) to fasted rats. The mixtures prepared at mass ratios of 1:10 and 1:20 (indicated by *) induced significant reductions in the blood glucose levels of the tested rats compared to the free insulin group at 0.5 and 4 h time intervals (P < 0.05). Abbreviations: GlcN, glucosamine; SC, subcutaneous; IU, insulin unit4 18

Effect of continuous oral GlcN HCl administration on insulin bioactivity. Notes: Rats were fed with GlcN HCl (25 mg GlcN HCl/mL) for 5 days. Blood glucose levels post SC insulin (I IU/kg) administration was significantly reduced when compared to rats offered water (P = 0.028). Abbreviations: GlcN, glucosamine; SC, subcutaneous; IU, insulin unit. 19

% Release of Insulin Effect of GlcN HCl on IC-RM bioactivity in diabetic rats. Notes: The hypoglycemic activity of IC-RM containing GlcN HCl was higher compared with IC-RM containing no GlcN HCl and the difference is significant (P<0.05). Abbreviations: GlcN, glucosamine; SC, subcutaneous; IU, insulin unit; IC, insulin-lmwc; PEC, polyelectrolyte complex; RM, reverse micelle; LMWC, Low molecular weight chitosan 20

It has been reported that GSH has an important role in the degradation and regulation of insulin 21

Percentage blood glucose levels in non-diabetic rats after subcutaneous (SC) administration of different doses of reduced glutathione (GSH) prior to SC insulin injection (1 IU/kg). Glucose measurements were performed at different time intervals (0 4 h). Each data point represents the mean SEM (n = 10). GSH significantly reduced the activity of insulin in a dose-dependent manner (p <0.05). 22

Percentage blood glucose levels in non-diabetic rats after subcutaneous (SC) administration of 50 mg/kg of reduced (GSH) or oxidized glutathione (GSSG) prior to SC insulin injection (1 IU/kg). Glucose measurements were performed at different time intervals (0 4 h). Each data point represents the mean SEM (n = 10). GSSG administration significantly enhanced hypoglycemia (p <0.05). 23

Percentage blood glucose levels in non-diabetic rats after subcutaneous (SC) administration of 50 mg/kg of reduced glutathione (GSH) at different time intervals prior to SC insulin injection (1 IU/kg). Glucose measurements were performed at different time intervals (0 4 h). Each data point represents the mean SEM (n = 10). 24

Percentage blood glucose levels in diabetic rats after oral administration of insulin-chitosan reverse micelle (IC-RM) containing 50 IU insulin/ml and different concentrations of reduced glutathione (GSH) in comparison with SC insulin injections (1 IU/kg). Glucose measurements were performed at different time intervals (0 10 h). Each data point represents the mean SEM (n = 10). The reduction in insulin activity was insignificant with GSH containing preparations (p > 0.05). 25

Percentage blood glucose levels in diabetic rats after oral administration of insulin-chitosan reverse micelles (IC-RM) containing 50 IU insulin/ml and 2.1 mg/kg of reduced (GSH) or oxidized glutathione (GSSG). Glucose measurements were performed at different time intervals (0 10 h). Each data point represents the mean SEM (n = 10). GSH (p > 0.05), GSSG (p < 0.05) compared to glutathione free preparations. 26

27

Thank You